Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 3/20 | 0.71 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.71 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.68 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.65 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.65 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.64 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.60 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.60 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.60 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.60 |
| ▸ | CA1 | P00915 | 2/20 | 0.58 |
| ▸ | CA2 | P00918 | 2/20 | 0.58 |
| ▸ | CA9 | Q16790 | 2/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5013872 | 1.00 | ESR1 (0.71) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL15902840 | 1.00 | ESR1 (0.71) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL30239998 | 1.00 | ESR1 (0.71) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL30239993 | 1.00 | ESR1 (0.71) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL30603836 | 1.00 | ESR1 (0.71) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL31039575 | 0.97 | ESR1 (0.76) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL18260181 | 0.97 | ESR1 (0.76) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL14994162 | 0.94 | ESR1 (0.65) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL3424690 | 0.94 | ESR1 (0.65) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL15842052 | 0.94 | ESR1 (0.65) | ESR1ESR2ALOX5HSD17B1HSD17B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 306 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250084302-A1 | ORGANIC COMPOUND AND LIGHT-EMITTING DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2025-03-13 | — | — | US | claimed |
| CN-108409682-A | A kind of chirality diazole and binaphthol derivative and its synthetic method | 华东师范大学 | 2018-08-17 | — | — | CN | claimed |
| EP-2970807-A1 | METHOD FOR IMPROVING THERMAL -OXIDATIVE STABILITY AND ELASTOMER COMPATIBILITY | ExxonMobil Research and Engineering Company (US) | 2016-01-20 | — | — | EP | claimed |
| US-9062269-B2 | Method for improving thermal-oxidative stability and elastomer compatibility | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2015-06-23 | — | — | US | claimed |
| WO-2014149406-A1 | METHOD FOR IMPROVING THERMAL -OXIDATIVE STABILITY AND ELASTOMER COMPATIBILITY | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2014-09-25 | — | — | WO | claimed |
| US-20140274836-A1 | METHOD FOR IMPROVING THERMAL-OXIDATIVE STABILITY AND ELASTOMER COMPATIBILITY | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2014-09-18 | — | — | US | claimed |
| US-20110077418-A1 | PROCESS FOR THE HYDROGENATION OF IMINES | CHEMINOVA A/S (DK) | 2011-03-31 | — | — | US | claimed |
| WO-2010094164-A1 | PROCESS FOR THE HYDROGENATION OF IMINES | CHEMINOVA A/S (DK) | 2010-08-26 | — | — | WO | claimed |
| US-20080306263-A1 | Process For The Preparation Of Optically Pure Tetrahydropterins And Derivatives, And Specifically Of Optically Pure Tetrahydrofolic Acid And Derivatives Thereof, By Stereospecific Hydrogenation | MULLER HANS RUDOLF | 2008-12-11 | — | — | US | claimed |
| US-7049453-B2 | “Constrained geometry” metallocenes, method for the production thereof and use of the same for the polymerisation of olefins | CELANESE VENTURES GMBH (DE) | 2006-05-23 | — | — | US | claimed |
| EP-1200437-B1 | METHOD FOR PRODUCING BY STEREOSPECIFIC HYDRATION TETRAHYDROPTERINS AND OPTICALLY PURE DERIVATIVES, IN PARTICULAR TETRAHYDROFOLIC ACID AND ITS OPTICALLY PURE DERIVATIVES | EPROVA AG (CH) | 2004-03-10 | — | — | EP | claimed |
| EP-1349863-A1 | NOVEL N-PHENYL-PYRROL BISPHOSPHANE COMPOUNDS AND THE METAL COMPLEXES OF THE SAME | Oxeno Olefinchemie GmbH (DE) | 2003-10-08 | — | — | EP | claimed |
| WO-2002055528-A1 | NOVEL N-PHENYL-PYRROL BISPHOSPHANE COMPOUNDS AND THE METAL COMPLEXES OF THE SAME | OXENO OLEFINCHEMIE GMBH (DE) | 2002-07-18 | — | — | WO | claimed |
| EP-1200437-A1 | METHOD FOR PRODUCING BY STEREOSPECIFIC HYDRATION TETRAHYDROPTERINS AND OPTICALLY PURE DERIVATIVES, IN PARTICULAR TETRAHYDROFOLIC ACID AND ITS OPTICALLY PURE DERIVATIVES | EPROVA AG Forschungsinstitut (CH) | 2002-05-02 | — | — | EP | claimed |
| EP-0850241-B1 | IRIDIUM-DIPHOSPHINE COMPLEXES AND PROCESS FOR THE HYDROGENATION OF IMINES | NOVARTIS AG (CH) | 2001-08-29 | — | — | EP | claimed |
| WO-2001004120-A1 | METHOD FOR PRODUCING BY STEREOSPECIFIC HYDRATION TETRAHYDROPTERINS AND OPTICALLY PURE DERIVATIVES, IN PARTICULAR TETRAHYDROFOLIC ACID AND ITS OPTICALLY PURE DERIVATIVES | EPROVA AG (CH) | 2001-01-18 | — | — | WO | claimed |
| US-6008393-A | A DITERTIARY DIPHOSPHINE WHICH IS BONDED TO A C2 TO C4 CARBON CHAIN, AND FORMS A 5 TO 7 MEMBERED RING WITH IRIDIUM HALIDE AND CONTAINING OXYACID ANION SUCH AS CARBOXYLIC ACID, SULFONIC ACID AND PHOSPHORIC ACID | NOVARTIS AG (CH) | 1999-12-28 | — | — | US | claimed |
| EP-0419409-B1 | Iridium complexes, process for their preparation and their use | CIBA GEIGY AG (CH) | 1995-11-02 | — | — | EP | claimed |
| US-5112999-A | With diphosphines and diphosphinites, catalysts for hydrogenation of imines to secondary amines | CIBA-GEIGY CORPORATION (US) | 1992-05-12 | — | — | US | claimed |
| EP-0419409-A2 | Iridium complexes, process for their preparation and their use | CIBA-GEIGY AG (CH) | 1991-03-27 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110077418-A1 | PROCESS FOR THE HYDROGENATION OF IMINES | INTS9, INTS6, INF2 | ESR1 2263/4885ESR2 1144/4885ALOX5 1384/4885 |
| US-20080306263-A1 | Process For The Preparation Of Optically Pure Tetrahydropterins And Derivatives, And Specifically Of Optically Pure Tetrahydrofolic Acid And Derivatives Thereof, By Stereospecific Hydrogenation | DHFR, MTHFD2, MTHFD1 | ESR1 4368/4885ESR2 4572/4885ALOX5 225/4885 |
| US-20250084302-A1 | ORGANIC COMPOUND AND LIGHT-EMITTING DEVICE | CRY1, C1S, DRD1 | ESR1 116/4885ESR2 602/4885ALOX5 2445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.